First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study
贝伐珠单抗联合艾立布林一线治疗HER2阴性转移性乳腺癌：GINECO II期ESMERALDA研究的疗效和安全性
期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2020.09.011
Hardy-Bessard, Anne-Claire; Brocard, Fabien; Clatot, Florian; Lortholary, Alain; You, Benoît; Grenier, Julien; Martin-Babau, Jérôme; Lucas, Brigitte; Meunier, Jérôme; Ferrero, Jean-Marc; Savoye, Aude-Marie; Marti, Adina; Despax, Raymond; Moullet, Isabelle; Emile, George
